Publication | Closed Access

Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation

Heart FailureCardiovascular DiseaseMedicineDiabetesCardiovascular PharmacologyPharmacotherapyDiabetes MellitusCardiac CareAtrial FibrillationPublic HealthPharmacologyCardiologyDiastolic FunctionAnesthesiology